We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Mylan Demands FDA Response To Petition On "Branded Generics"

Law360 (July 1, 2004, 12:00 AM EDT) -- U.S. generic drug maker Mylan Laboratories has supplemented a petition with the U.S. Food and Drug Administration, seeking an immediate response to its claim that branded drugmakers are unfairly undermining sales of generic drugmakers.

Mylan’s "citizens petition," submitted to the FDA in February, calls for the FDA to prevent makers of branded drugs from marketing their drugs as so-called "authorized generics.”

In its petition, Mylan requested that the FDA "prohibit the marketing and distribution of 'authorized generic' versions of brand name drugs until the expiration of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.